Testing effectiveness (Phase 2)Study completedNCT00055939What this trial is testingExatecan Mesylate in Treating Children With Relapsed or Refractory RhabdomyosarcomaWho this might be right forSarcoma Daiichi Sankyo
Testing effectiveness (Phase 2)Ended earlyNCT00617929What this trial is testingAntithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell TransplantWho this might be right forCancer Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)Study completedNCT01427881What this trial is testingCyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Megakaryoblastic Leukemia (M7)+65 more Fred Hutchinson Cancer Center 43
Testing effectiveness (Phase 2)Active Not RecruitingNCT03660826What this trial is testingTesting the Combination of Olaparib and Durvalumab, Cediranib and Durvalumab, Olaparib and Capivasertib, and Cediranib Alone in Recurrent or Refractory Endometrial Cancer Following the Earlier Phase of the Study That Tested Olaparib and Cediranib in Comparison to Cediranib Alone, and Olaparib AloneWho this might be right forEndometrial AdenocarcinomaEndometrial Mixed Cell AdenocarcinomaEndometrial Serous Adenocarcinoma+3 more National Cancer Institute (NCI)
Early research (Phase 1)Active Not RecruitingNCT05362773What this trial is testingMGD024 in Patients With Relapsed or Refractory Hematologic MalignanciesWho this might be right forLeukemia, Acute MyeloidMyelodysplastic SyndromesClassical Hodgkin Lymphoma+5 more MacroGenics 130
Early research (Phase 1)WithdrawnNCT00458744What this trial is testingTalotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWho this might be right forBrain and Central Nervous System TumorsLeukemiaLymphoma+1 more Children's Oncology Group
Testing effectiveness (Phase 2)Ended earlyNCT00717522What this trial is testingEfficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue SarcomaWho this might be right forSoft Tissue Sarcoma Celgene 7
Testing effectiveness (Phase 2)Study completedNCT00004132What this trial is testingGrowth Factor to Prevent Oral Mucositis in Patients With Hematologic CancerWho this might be right forDrug/Agent Toxicity by Tissue/OrganLeukemiaLymphoma+3 more Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00082823What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Looking for participantsNCT04616560What this trial is testingTrastuzumab Deruxtecan (DS-8201a) for the Treatment of Recurrent or Refractory Osteosarcoma, Wilms Tumor, and Desmoplastic Small Round Cell TumorWho this might be right forDesmoplastic Small Round Cell TumorOsteosarcomaRecurrent Desmoplastic Small Round Cell Tumor+5 more National Cancer Institute (NCI) 55
Not applicableUnknownNCT03582527What this trial is testingPD-L1 Expression in Advanced OsteosarcomaWho this might be right forProgressionSurvival Peking University People's Hospital 50
Early research (Phase 1)Ended earlyNCT05128786What this trial is testingCCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive SarcomasWho this might be right forSAR Shanghai PerHum Therapeutics Co., Ltd. 9
Early research (Phase 1)Study completedNCT00005988What this trial is testingBone Marrow Transplantation With Specially Treated Bone Marrow in Treating Patients With Hematologic Cancer That Have Not Responded to Previous TherapyWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Study completedNCT00003661What this trial is testingChemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic CancerWho this might be right forGraft Versus Host DiseaseLeukemiaLymphoma+2 more Roswell Park Cancer Institute 3
Testing effectiveness (Phase 2)Study completedNCT01529827What this trial is testingFludarabine Phosphate, Melphalan, and Low-Dose Total-Body Irradiation Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic MalignanciesWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+75 more Roswell Park Cancer Institute 94
Testing effectiveness (Phase 2)UnknownNCT00021385What this trial is testingSqualamine Lactate Plus Carboplatin in Treating Patients With Recurrent or Refractory Stage III or Stage IV Ovarian CancerWho this might be right forOvarian Cancer Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01282476What this trial is testingPanobinostat With Rituximab for Relapsed/Refractory Diffuse Large B Cell LymphomaWho this might be right forDiffuse Large B Cell Lymphoma Massachusetts General Hospital 18
Testing effectiveness (Phase 2)WithdrawnNCT04791228What this trial is testingA Pilot Study of Thermodox and MR-HIFU for Treatment of Relapsed Solid TumorsWho this might be right forSolid TumorsSoft Tissue SarcomaEwing Sarcoma+6 more Children's National Research Institute
Testing effectiveness (Phase 2)Ended earlyNCT03509207What this trial is testingVorinostat (SAHA) in Uterine SarcomaWho this might be right forLeiomyosarcomaEndometrial Stromal TumorsCarcinosarcomas Uterine Medical University of Graz 3
Testing effectiveness (Phase 2)Looking for participantsNCT07479732What this trial is testingApatinib Combined With Liposomal Irinotecan for Refractory or Metastatic OsteosarcomaWho this might be right forOsteosarcomaOsteosarcoma Metastatic Peking University People's Hospital 56